医学
甲状腺癌
淋巴结
淋巴
甲状腺癌
癌症分期
转移
甲状腺
癌
内科学
癌症
肿瘤科
病理分期
临床意义
甲状腺乳突癌
放射科
阶段(地层学)
病理
古生物学
生物
作者
Gregory W. Randolph,Quan‐Yang Duh,Keith S. Heller,Virginia A. LiVolsi,Susan J. Mandel,David L. Steward,Ralph P. Tufano,for the American Thyroid As R. Michael Tuttle
出处
期刊:Thyroid
[Mary Ann Liebert, Inc.]
日期:2012-10-19
卷期号:22 (11): 1144-1152
被引量:841
标识
DOI:10.1089/thy.2012.0043
摘要
Our previous paradigm assigned the same magnitude of risk for all patients with N1 disease. However, small-volume subclinical microscopic N1 disease clearly conveys a much smaller risk of recurrence than large-volume, macroscopic clinically apparent loco-regional metastases. Armed with this information, clinicians will be better able to tailor initial treatment and follow-up recommendations. Implications of N1 stratification for PTC into small-volume microscopic disease versus clinically apparent macroscopic disease importantly relate to issues of prophylactic neck dissection utility, need for pathologic nodal size description, and suggest potential modifications to the AJCC TNM (tumor, nodal disease, and distant metastasis) and ATA risk recurrence staging systems.
科研通智能强力驱动
Strongly Powered by AbleSci AI